Partners

AmpliPhi Biosciences intends to develop the commercial potential of its products through licensing partners on a global basis. AmpliPhi will develop its lead products through initial clinical development and then seek global and/or regional partners.

In the meantime, AmpliPhi welcomes approaches from interested partners, as well as companies wishing to co-develop AmpliPhi’s technology in other ways.

Latest News

January 31st 2012

January 2012 Shareholder Letter

More

January 04th 2012

BioWorld Today features AmpliPhi CEO Phil Young

More

November 21st 2011

AmpliPhi Biosciences Announces First Closing of $2.7m

More

November 08th 2011

AmpliPhi Biosciences appoints Philip J. Young as President and CEO

More

September 06th 2011

AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New York

More